David-Alexandre C. Gros
2015 - Alnylam Pharmaceuticals
In 2015, David-Alexandre C. Gros earned a total compensation of $10.2M as Senior Vice President, Chief Business Officer at Alnylam Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $95,819 |
| Option Awards | $9,630,797 |
| Salary | $241,106 |
| Other | $508 |
| Total | $10,168,230 |
Gros received $9.6M in option awards, accounting for 95% of the total pay in 2015.
Gros also received $200K in bonus, $95.8K in non-equity incentive plan, $241.1K in salary and $508 in other compensation.
Rankings
In 2015, David-Alexandre C. Gros' compensation ranked 487th out of 13,638 executives tracked by ExecPay. In other words, Gros earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 487 out of 13,638 | 96th |
Division Manufacturing | 162 out of 5,190 | 97th |
Major group Chemicals And Allied Products | 64 out of 1,854 | 97th |
Industry group Drugs | 51 out of 1,528 | 97th |
Industry Pharmaceutical Preparations | 40 out of 1,182 | 97th |
Source: SEC filing on March 17, 2016.
Gros' colleagues
We found four more compensation records of executives who worked with David-Alexandre C. Gros at Alnylam Pharmaceuticals in 2015.
2015
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2015
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2015
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2015
Michael Mason
Alnylam Pharmaceuticals